Published by Abigail Townsend on 13th February 2025
(Sharecast News) - UBS has upgraded AstraZeneca to a 'buy', citing the London-listed pharmaceutical firm's "sector-leading" drug pipeline.
URL: http://www.digitallook.com/dl/news/story/34879589/...